Sanofi – Cop 21 - First Step to Act on Infectious Diseases Evolution Due to Climate Change

Primary tabs

Sanofi – Cop 21 - First Step to Act on Infectious Diseases Evolution Due to Climate Change

tweet me:
Sanofi – Cop 21 - First Step to Act on Infectious Diseases Evolution Due to Climate Change. http://3bl.me/csyske

Multimedia from this Release

Friday, January 8, 2016 - 10:55am

CAMPAIGN: Sanofi Global

CONTENT: Multimedia with summary

Laurent Fraisse, head of research on infectious diseases at Sanofi, explains how research can help tackling infectious diseases evolution due to climate change.

Watch more Sanofi videos! Vist our YouTube page at SanofiTV!  

About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

 

Keywords: Environment | COP21 | Corporate Social Responsibility | Dengue Fever | Global Warming | Infectious Disease | Malaria | Sanofi | climate change | co2 emission | csr

CAMPAIGN: Sanofi Global

CONTENT: Multimedia with summary

parse.ly